These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38473722)

  • 1. Immunological Landscapes in Lung Transplantation: Insights from T Cell Profiling in BAL and PBMC.
    de Silva TA; Apte S; Voisey J; Spann K; Tan M; Chambers D; O'Sullivan B
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosis.
    Sinclair KA; Yerkovich ST; Hopkins PM; Fieuw AM; Ford P; Powell JE; O'Sullivan B; Chambers DC
    J Heart Lung Transplant; 2021 Jan; 40(1):12-23. PubMed ID: 33339555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant arteriosclerosis in humanized mice reflects chronic lung allograft dysfunction and is controlled by regulatory T cells.
    Siemeni T; Knöfel AK; Ius F; Sommer W; Salman J; Böthig D; Falk CS; Tudorache I; Haverich A; Warnecke G
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2528-2537. PubMed ID: 30955963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction-free survival.
    Greenland NY; Deiter F; Calabrese DR; Hays SR; Kukreja J; Leard LE; Kolaitis NA; Golden JA; Singer JP; Greenland JR
    Clin Transplant; 2022 Jun; 36(6):e14639. PubMed ID: 35246990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory and Effector Cell Disequilibrium in Patients with Acute Cellular Rejection and Chronic Lung Allograft Dysfunction after Lung Transplantation: Comparison of Peripheral and Alveolar Distribution.
    Bergantini L; d'Alessandro M; De Vita E; Perillo F; Fossi A; Luzzi L; Paladini P; Perrone A; Rottoli P; Sestini P; Bargagli E; Bennett D
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Expression Profiling of Bronchoalveolar Lavage Cells Preceding a Clinical Diagnosis of Chronic Lung Allograft Dysfunction.
    Weigt SS; Wang X; Palchevskiy V; Gregson AL; Patel N; DerHovanessian A; Shino MY; Sayah DM; Birjandi S; Lynch JP; Saggar R; Ardehali A; Ross DJ; Palmer SM; Elashoff D; Belperio JA
    PLoS One; 2017; 12(1):e0169894. PubMed ID: 28103284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchoalveolar lavage cytokine-based risk stratification of minimal acute rejection in clinically stable lung transplant recipients.
    Levy L; Huszti E; Ahmed M; Ghany R; Hunter S; Moshkelgosha S; Zhang CYK; Boonstra K; Klement W; Tikkanen J; Singer LG; Keshavjee S; Juvet S; Martinu T
    J Heart Lung Transplant; 2021 Dec; 40(12):1540-1549. PubMed ID: 34215500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
    Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
    Front Immunol; 2021; 12():661761. PubMed ID: 34122421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Flow Cytometric Characterization of Bronchoalveolar Lavage Cells Indicates Comparable Phenotypes Between Asthmatic and Healthy Horses But Functional Lymphocyte Differences.
    Gressler AE; Lübke S; Wagner B; Arnold C; Lohmann KL; Schnabel CL
    Front Immunol; 2022; 13():896255. PubMed ID: 35874777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.
    Shino MY; Weigt SS; Li N; Derhovanessian A; Sayah DM; Saggar R; Huynh RH; Gregson AL; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2018 Jan; 18(1):136-144. PubMed ID: 28637080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased intracellular pro- and anti-inflammatory cytokines in bronchoalveolar lavage T cells of stable lung transplant patients.
    Hodge G; Hodge S; Reynolds PN; Holmes M
    Transplantation; 2005 Oct; 80(8):1040-5. PubMed ID: 16278583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway infection in stable lung transplant patients is associated with decreased intracellular T-helper type 1 pro-inflammatory cytokines in bronchoalveolar lavage T-cell subsets.
    Hodge G; Hodge S; Reynolds PN; Holmes M
    Transpl Infect Dis; 2008 Apr; 10(2):99-105. PubMed ID: 17511818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of bronchoalveolar lavage from human lung transplant recipients by flow cytometry.
    Whitehead BF; Stoehr C; Finkle C; Patterson G; Theodore J; Clayberger C; Starnes VA
    Respir Med; 1995 Jan; 89(1):27-34. PubMed ID: 7708976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of bile acids in large airway bronchial wash versus bronchoalveolar lavage as biomarkers of microaspiration in lung transplant recipients: a retrospective cohort study.
    Zhang CYK; Ahmed M; Huszti E; Levy L; Hunter SE; Boonstra KM; Moshkelgosha S; Sage AT; Azad S; Ghany R; Yeung JC; Crespin OM; Singer LG; Keshavjee S; Martinu T
    Respir Res; 2022 Aug; 23(1):219. PubMed ID: 36028826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial cell death markers in bronchoalveolar lavage correlate with chronic lung allograft dysfunction subtypes and survival in lung transplant recipients-a single-center retrospective cohort study.
    Levy L; Tigert A; Huszti E; Saito T; Mitsakakis N; Moshkelgosha S; Joe B; Boonstra KM; Tikkanen JM; Keshavjee S; Juvet SC; Martinu T
    Transpl Int; 2019 Sep; 32(9):965-973. PubMed ID: 31002407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial and Erythrocyte Microvesicles From Bronchoalveolar Lavage Fluid Are Elevated and Associated With Outcome in Chronic Lung Allograft Dysfunction.
    Harms A; Fuehner T; Warnecke G; Haverich A; Gottlieb J; Trummer A
    Transplantation; 2015 Nov; 99(11):2394-400. PubMed ID: 26451527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients.
    Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR
    Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.
    Todd JL; Weber JM; Kelly FL; Neely ML; Mulder H; Frankel CW; Nagler A; McCrae C; Newbold P; Kreindler J; Palmer SM
    Chest; 2023 Sep; 164(3):670-681. PubMed ID: 37003354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients.
    Schneck E; Askevold I; Rath R; Hecker A; Reichert M; Guth S; Koch C; Sander M; Seeger W; Mayer K; Padberg W; Sommer N; Kuhnert S; Hecker M
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.